Last Updated:
Name Designation Appointment Date Status
Bhushan Vinayak Satpute

Appointed as Director since August 2021

 Director 19-Aug-2021 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Sushena Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Girish Ganpatbhai Mewada

Appointed as Director since August 2021

 Director 19-Aug-2021 Current
Venkatesh Srinivasan Iyengar

Appointed as Director since August 2021

 Director 19-Aug-2021 Current

People Timeline

Explore the timeline of key personnel in Sushena Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address 304 Kesarinath Apartments S V Road Near Filmistan Studio Goregaon West, Mumbai Maharashtra, 400104, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 400104
  • Country India
  • Website -
Frequently Asked Questions
You can contact Sushena Pharmaceuticals Private Limited through their registered address at 304 Kesarinath Apartments S V Road Near Filmistan Studio Goregaon West, Mumbai Maharashtra, 400104, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Sushena Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • BHUSHAN VINAYAK SATPUTE
  • GIRISH GANPATBHAI MEWADA
  • VENKATESH SRINIVASAN IYENGAR
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available